{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:51:05Z","timestamp":1770486665211,"version":"3.49.0"},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":298,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Big Lottery"},{"name":"Hedley Foundation"},{"name":"Tees, Esk and Wear Valleys NHS Foundation Trust (NIHR Flexibility and Sustainability Funding)"},{"name":"Trial Steering Committee and Data Monitoring Committee"},{"name":"King's Clinical Trials Unit at the Institute of Psychiatry"},{"name":"UK Mental Health Research Network"},{"name":"UK National Treatment Agency for Substance Misuse for the Department of Health and the Home Office"},{"name":"NIHR Biomedical Research Centre for Mental Health at South London"},{"name":"Maudsley NHS Foundation Trust and King's College London"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1111\/add.12748","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T07:29:25Z","timestamp":1411457365000},"page":"479-490","source":"Crossref","is-referenced-by-count":24,"title":["Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT)"],"prefix":"10.1111","volume":"110","author":[{"given":"Nicola","family":"Metrebian","sequence":"first","affiliation":[{"name":"Addictions Department; Institute of Psychiatry Psychology and Neuroscience; Kings College London; London UK"}]},{"given":"Teodora","family":"Groshkova","sequence":"additional","affiliation":[{"name":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); Lisbon Portugal"}]},{"given":"Jennifer","family":"Hellier","sequence":"additional","affiliation":[{"name":"Department of Biostatistics; Institute of Psychiatry Psychology and Neuroscience; Kings College London; London UK"}]},{"given":"Vikki","family":"Charles","sequence":"additional","affiliation":[{"name":"Addictions Department; Institute of Psychiatry Psychology and Neuroscience; Kings College London; London UK"}]},{"given":"Anthea","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Biostatistics; Institute of Psychiatry Psychology and Neuroscience; Kings College London; London UK"}]},{"given":"Luciana","family":"Forzisi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics; Institute of Psychiatry Psychology and Neuroscience; Kings College London; London UK"}]},{"given":"Nicholas","family":"Lintzeris","sequence":"additional","affiliation":[{"name":"The Langton Centre; Drug and Alcohol Services; South East Sydney Local Health District and Division of Addiction Medicine; Sydney University; Sydney Australia"}]},{"given":"Deborah","family":"Zador","sequence":"additional","affiliation":[{"name":"Justice Health and Forensic Mental Health Network; NSW Ministry of Health; Sydney Australia"}]},{"given":"Hugh","family":"Williams","sequence":"additional","affiliation":[{"name":"Sussex Partnership NHS Trust; West Sussex UK"}]},{"given":"Tom","family":"Carnwath","sequence":"additional","affiliation":[{"name":"Atkinson Lewis Ltd; Swansea UK"}]},{"given":"Soraya","family":"Mayet","sequence":"additional","affiliation":[{"name":"Tees, Esk and Wear Valleys, NHS Foundation Trust; Durham UK"}]},{"given":"John","family":"Strang","sequence":"additional","affiliation":[{"name":"Addictions Department; Institute of Psychiatry Psychology and Neuroscience; Kings College London; London UK"},{"name":"South London and Maudsley NHS Foundation Trust; London UK"}]}],"member":"311","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"10.1111\/add.12748-BIB0001|add12748-cit-0001","unstructured":"Department of Health, National Treatment Agency for Substance Misuse 2012 Statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2011-31 March 2012 1"},{"key":"10.1111\/add.12748-BIB0002|add12748-cit-0002","volume-title":"Methadone and Buprenorphine for the Management of Opioid Dependence Technology Appraisal 114","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2007"},{"key":"10.1111\/add.12748-BIB0003|add12748-cit-0003","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000101550","article-title":"Pathways into receiving a prescription for diamorphine (heroin) for the treatment of opiate dependence in the United Kingdom","volume":"13","author":"Metrebian","year":"2007","journal-title":"Eur Addict Res"},{"key":"10.1111\/add.12748-BIB0004|add12748-cit-0004","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1046\/j.1360-0443.2002.00193.x","article-title":"Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom","volume":"97","author":"Metrebian","year":"2002","journal-title":"Addiction"},{"key":"10.1111\/add.12748-BIB0005|add12748-cit-0005","doi-asserted-by":"crossref","DOI":"10.1159\/isbn.978-3-318-00369-7","volume-title":"Prescription of Narcotics for Heroin Addicts: Main Results of the Swiss National Cohort Study","author":"Uchtenhagen","year":"1999"},{"key":"10.1111\/add.12748-BIB0006|add12748-cit-0006","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.317.7150.13","article-title":"Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments","volume":"317","author":"Perneger","year":"1998","journal-title":"BMJ"},{"key":"10.1111\/add.12748-BIB0007|add12748-cit-0007","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.327.7410.310","article-title":"Medical prescription of heroin to treatment resistant heroin addicts: two randomized controlled trials","volume":"327","author":"Van den Brink","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/add.12748-BIB0008|add12748-cit-0008","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jsat.2006.04.007","article-title":"Controlled trial of prescribed heroin in the treatment of opioid addiction","volume":"31","author":"March","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"10.1111\/add.12748-BIB0009|add12748-cit-0009","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","article-title":"Heroin-assisted treatment for opioid dependence","volume":"191","author":"Haasen","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1111\/add.12748-BIB0010|add12748-cit-0010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"N Engl J Med"},{"issue":"issue 12","key":"10.1111\/add.12748-BIB0011|add12748-cit-0011","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003410.pub4","article-title":"Heroin maintenance for chronic heroin-dependent individuals","author":"Feri","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/add.12748-BIB0012|add12748-cit-0012","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(10)60349-2","article-title":"Supervised injectable heroin or injectable methadone versus optimized oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomized trial","volume":"375","author":"Strang","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/add.12748-BIB0013|add12748-cit-0013","unstructured":"Department of Health, UK 2012 https:\/\/www.gov.uk\/government\/news\/injectable-opioid-treatment-invitation-to-a-service-provider-briefing www.webcitation.org\/6TOGGhRXF"},{"key":"10.1111\/add.12748-BIB0014|add12748-cit-0014","volume-title":"Injectable heroin (and injectable methadone). Potential Roles in Drug Treatment: Full Guidance Report","author":"National Treatment Agency for Substance Misuse.","year":"2003"},{"key":"10.1111\/add.12748-BIB0015|add12748-cit-0015","volume-title":"Drug Misuse and Dependence: Guidelines on Clinical Management","author":"Department of Health","year":"1999"},{"key":"10.1111\/add.12748-BIB0016|add12748-cit-0016","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1477-7517-3-28","article-title":"Methodology for the Randomised Injecting Opiate Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK","volume":"3","author":"Lintzeris","year":"2006","journal-title":"Harm Reduct J"},{"key":"10.1111\/add.12748-BIB0017|add12748-cit-0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1360-0443.1992.tb02719.x","article-title":"Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index","volume":"87","author":"Darke","year":"1992","journal-title":"Br J Addict"},{"key":"10.1111\/add.12748-BIB0018|add12748-cit-0031","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1111\/add.12748-BIB0019|add12748-cit-0017","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.drugalcdep.2010.06.013","article-title":"Benzodiazepine use among patients in heroin-assisted vs methadone maintenance treatment. Findings of the German randomised controlled trial","volume":"112","author":"Eiroa-Orosa","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/add.12748-BIB0020|add12748-cit-0018","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/dar.12062","article-title":"Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics","volume":"32","author":"Groshkova","year":"2013","journal-title":"Drug Alcohol Rev"},{"key":"10.1111\/add.12748-BIB0021|add12748-cit-0019","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1037\/0893-164X.11.4.324","article-title":"The National Treatment Outcome Research Study in the United Kingdom: six-month follow-up outcomes","volume":"11","author":"Gossop","year":"1997","journal-title":"Psychol Addict Behav"},{"key":"10.1111\/add.12748-BIB0022|add12748-cit-0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.alcohol.2009.02.007","article-title":"Effects of heroin assisted treatment on alcohol consumption. Findings of the German randomised controlled trial","volume":"43","author":"Haasen","year":"2009","journal-title":"Alcohol"},{"key":"10.1111\/add.12748-BIB0023|add12748-cit-0021","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/bmj.306.6890.1440","article-title":"The SF36 Health Survey Questionnaire: an outcome measure suitable for routine use within the NHS?","volume":"306","author":"Garratt","year":"1993","journal-title":"BMJ"},{"key":"10.1111\/add.12748-BIB0024|add12748-cit-0022","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/bmj.306.6890.1437","article-title":"Short Form 36 (SF36) health survey questionnaire: normative data for adults of working age","volume":"306","author":"Jenkinson","year":"1993","journal-title":"BMJ"},{"key":"10.1111\/add.12748-BIB0025|add12748-cit-0023","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00005650-199704000-00010","article-title":"Development and testing of the medical outcome study 36-item short form health survey summary scale scores in the United Kingdom","volume":"35","author":"Jenkinson","year":"1997","journal-title":"Med Care"},{"key":"10.1111\/add.12748-BIB0026|add12748-cit-0024","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1360-0443.1996.tb03160.x","article-title":"Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire","volume":"91","author":"Ryan","year":"1996","journal-title":"Addiction"},{"key":"10.1111\/add.12748-BIB0027|add12748-cit-0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/09595230412331289428","article-title":"Health status of clients receiving methadone maintenance treatment using the SF-36 health survey questionnaire","volume":"23","author":"Deering","year":"2004","journal-title":"Drug Alcohol Rev"},{"key":"10.1111\/add.12748-BIB0028|add12748-cit-0026","unstructured":"Gossop M. Marsden J. Stewart D. NTORS at One Year. The National Treatment Outcome Research Study Changes in Substance Use, Health and Criminal Behaviour One year after Intake 1998"},{"key":"10.1111\/add.12748-BIB0029|add12748-cit-0027","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.drugalcdep.2010.06.009","article-title":"Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence","volume":"112","author":"Karow","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/add.12748-BIB0030|add12748-cit-0028","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000274177","article-title":"Effects of psychiatric comorbidity on treatment outcomes in patients undergoing diamorphine or methadone maintenance","volume":"43","author":"Scafer","year":"2010","journal-title":"Psychopathology"},{"key":"10.1111\/add.12748-BIB0031|add12748-cit-0029","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1192\/bjp.bp.112.111583","article-title":"Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction","volume":"203","author":"Byford","year":"2013","journal-title":"Br J Psychiatry"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.12748","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.12748","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/add.12748\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T10:55:55Z","timestamp":1625309755000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.12748"}},"subtitle":["RIOTT secondary outcomes"],"short-title":[],"issued":{"date-parts":[[2014,11,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1111\/add.12748","archive":["Portico"],"relation":{},"ISSN":["0965-2140"],"issn-type":[{"value":"0965-2140","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11,7]]}}}